Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine
Reference51 articles.
1. Adelson KB, Loprinzi CL, Hershman DL (2005) Treatment of hot flushes in breast and prostate cancer. Expert Opin Pharmacother 6:1095–1106
2. Anderson J (2003) The role of antiandrogen monotherapy in the treatment of prostate cancer. BJU Int 91:455–461
3. Aus G, Abbou CC, Bolla M, Heidenreich A, Van Poppel H, Schmid H-P, Wolff JM, Zattoni F (2005) European Association of Urology guidelines on prostate cancer. http://www.uroweb.nl/files/uploaded_files/2005Prostate%20Cancer.pdf (accessed 19 December 2005)
4. Barradell LB, Faulds D (1994) Cyproterone. A review of its pharmacology and therapeutic efficacy in prostate cancer. Drugs Aging 5:59–80
5. Berruti A, Dogliotti L, Terrone C, Cerruti S, Isaia G, Tarabuzzi R, Reimondo G, Mari M, Ardissone P, De Luca S, Fasolis G, Fontana D, Rossetti SR, Angeli A, Gruppo Onco Urologico Piemontese (GOUP) ROP (2002) Changes in bone mineral density, lean body mass and fat content as measured by dual energy x-ray absorptiometry in patients with prostate cancer without apparent bone metastases given androgen deprivation. J Urol 167:2361–2367
Cited by
44 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献